Clinical Trials

Overview

About this study

Phase I: The purpose of this study is to identify patients with common or rare variants in genes related to HCM, Long QT syndrome, arrhythmogenic right ventricular cardiomyopathy, dilated cardiomyopathy, and ATTR amyloidosis and run our previously developed and validated AI-ECG models on these pateints' ECGs to identify patients who have ECG abnormalities.

Phase II: Collect detailed “digital phenotypes” of the patients identified in Phase I. "Digital phenotypes" will be collected through survey responses, Apple HealthKit data (including Apple Watch ECG), voice recordings and EMR data.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Participating Mayo Clinic locations

More information